A five year review of scar dehiscence in the Rotunda Hospital, Dublin.
The aims of this study were to identify risk factors for scar dehiscence in labour, to illustrate the clinical presentations of patients with scar dehiscence and to quantify the risk posed by the use of oxytocin in labour. This was a case controlled, 5 year retrospective study. Patients with scar dehiscence were identified from labour ward records with matched controls and chart review of case and control patients were performed. Our results showed that the vaginal delivery rate for trial of scar was 76.9%. The incidence of scar dehiscence was 0.043%. Oxytocic labour augmentation was a risk factor (OR 4.5, 95% CI 0.9313-42.8, p=0.065) but induction of labour using oxytocin was not (p=0.222). The commonest symptom of scar dehiscence was fetal distress (OR 12.3, 95% CI 1.9-81). There was no maternal or fetal mortality. We concluded that trial of labour after one caesarean section is acceptable practice with a good success rate and a low incidence of serious morbidity. The use of oxytocin to augment labour is associated with scar dehiscence.
Connolly
G
G
Rotunda Hospital, Dublin, Ireland. gconnolly@rotunda.ie
Razak
A
A
Conroy
R
R
Harrison
R
R
McKenna
P
P
D000328:Adult; D016022:Case-Control Studies; D015984:Causality; D002585:Cesarean Section / Q000706:statistics & numerical data; D036861:Delivery, Obstetric / Q000379:methods; D005260:Female; D006801:Humans; D007494:Ireland / Q000453:epidemiology; D007751:Labor, Induced; D009017:Morbidity; D007744:Obstetric Labor Complications / Q000453:epidemiology; D010121:Oxytocin / Q000627:therapeutic use; D011247:Pregnancy; D012189:Retrospective Studies; D012307:Risk Factors; D014219:Trial of Labor
D010121:Oxytocin